Small lung nodules warrant closer monitoring; 15% found to be cancer

Lung cancer is Brazil's deadliest cancer type with 32,400 projected deaths annually; delayed diagnosis from incidental nodules costs patients critical early treatment windows when survival rates exceed 90%.

A small shadow on a chest scan, ordered for reasons unrelated to the lungs, has long been treated as a footnote in medicine — noted, filed, and forgotten. But a Brazilian study now reveals that 15 percent of these incidentally discovered nodules are malignant, six times the rate found in active screening programs, suggesting that what doctors have been calling reassuring may in fact be a quiet emergency. In a country where lung cancer claims more than 32,000 lives each year, the gap between discovery and diagnosis — averaging 11 months — represents not just a clinical failure, but a human one:

Small lung nodules warrant closer monitoring; 15% found to be cancer

Cobertura Relacionada

Recibe The Register en tu bandeja